Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Molecular function
- GO: Cellular component
- GO: Biological process
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: itih3a.1 ENSDARG00000055036

.

Description

inter-alpha-trypsin inhibitor heavy chain 3a, tandem duplicate 1 [Source:ZFIN;Acc:ZDB-GENE-050522-262]

Location

Chromosome 11: 3,614,326-3,629,216 reverse strand.

GRCz11:CM002895.2

About this gene

This gene has 3 transcripts (splice variants), 297 orthologues and 13 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	Flags
ENSDART00000132121.3	itih3a.1-201	2975	905aa	ENSDARP00000113767.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000136577.2	itih3a.1-202	810	259aa	ENSDARP00000118330.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,
ENSDART00000141710.2	itih3a.1-203	651	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-

.

Summary

.

.